國立虎尾科技大學 |

Drug Resistance in Leishmania Parasites = Consequences, Molecular Mechanisms and Possible Treatments /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Drug Resistance in Leishmania Parasites/ edited by Alicia Ponte-Sucre, Maritza Padrón-Nieves.
Reminder of title:	Consequences, Molecular Mechanisms and Possible Treatments /
other author:	Ponte-Sucre, Alicia.
Description:	XVII, 376 p. 24 illus., 14 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Drug resistance. -
Online resource:	https://doi.org/10.1007/978-3-319-74186-4
ISBN:	9783319741864

Drug Resistance in Leishmania Parasites = Consequences, Molecular Mechanisms and Possible Treatments /
Drug Resistance in Leishmania ParasitesConsequences, Molecular Mechanisms and Possible Treatments /[electronic resource] :edited by Alicia Ponte-Sucre, Maritza Padrón-Nieves. - 2nd ed. 2018. - XVII, 376 p. 24 illus., 14 illus. in color.online resource.

Prologue -- Introduction -- Part I Determinant features in Leishmaniasis -- Molecular evolution and phylogeny of Leishmania -- The role of reservoirs: canine Leishmaniasis -- Epidemiology of Leishmaniasis in the time of drug resistance -- The role of the immune system in resistance to infection -- Part II Challenges in the diagnosis, treatment and control of Leishmaniasis in the times of drug resistance -- Co-infection with HIV -- Visceral Leishmaniasis -- Tegumentary Leishmaniasis -- Antimony accounted sequel post Kala-Azar dermal Leishmaniasis -- Part III Molecular featrues of drug resistant Leishmania -- Genetic Expression and drug resistance, the role of proteomics -- The role of AMC transporters in drug-resistant Leishmania -- Functional analysis of Leishmania membrane (non AMC) transporters involved in drug resistance -- Part IV Pharmacology and chemotherapy of Leishmaniasis -- Classical vs. novel treatment regimens -- Bioinformatics in Leishmania drug design -- Leishmanis mitochondria, a druggable organelle -- P-glycoprotein-like transporters in Leishmania: a search for reversal agents -- Part V Strategies to circumvent drug resistance in Leishmania -- The relevance of susceptibility tests, breakpoints and markers -- The concept of fitness in Leishmania.

Drug resistance is a fundamental factor in treatment failure in diseases like leishmaniasis, although additional factors also play a role in this phenomenon. This volume is the second edition of a well-received book that provides a comprehensive update on the pathology of the disease, as well as on the concept of parasitic drug resistance, its molecular basis, consequences and possible treatments. A valuable resource for scientists both from academia and industry involved in biomedical research and drug design, the book provides the knowledge needed to understand leishmaniasis and to contibute to combatting this disease worldwide.

ISBN: 9783319741864

Standard No.: 10.1007/978-3-319-74186-4doiSubjects--Topical Terms:

872072
Drug resistance.

LC Class. No.: QR177

Dewey Class. No.: 616.9041

Drug Resistance in Leishmania Parasites = Consequences, Molecular Mechanisms and Possible Treatments /
LDR:03366nam a22003975i 4500 001 991171
003 DE-He213
005 20200703143247.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319741864 $9 978-3-319-74186-4
024 7 $a 10.1007/978-3-319-74186-4 $2 doi
035 $a 978-3-319-74186-4
050 4 $a QR177
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 616.9041 $2 23
245 1 0 $a Drug Resistance in Leishmania Parasites $h [electronic resource] : $b Consequences, Molecular Mechanisms and Possible Treatments / $c edited by Alicia Ponte-Sucre, Maritza Padrón-Nieves.
250 $a 2nd ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a XVII, 376 p. 24 illus., 14 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Prologue -- Introduction -- Part I Determinant features in Leishmaniasis -- Molecular evolution and phylogeny of Leishmania -- The role of reservoirs: canine Leishmaniasis -- Epidemiology of Leishmaniasis in the time of drug resistance -- The role of the immune system in resistance to infection -- Part II Challenges in the diagnosis, treatment and control of Leishmaniasis in the times of drug resistance -- Co-infection with HIV -- Visceral Leishmaniasis -- Tegumentary Leishmaniasis -- Antimony accounted sequel post Kala-Azar dermal Leishmaniasis -- Part III Molecular featrues of drug resistant Leishmania -- Genetic Expression and drug resistance, the role of proteomics -- The role of AMC transporters in drug-resistant Leishmania -- Functional analysis of Leishmania membrane (non AMC) transporters involved in drug resistance -- Part IV Pharmacology and chemotherapy of Leishmaniasis -- Classical vs. novel treatment regimens -- Bioinformatics in Leishmania drug design -- Leishmanis mitochondria, a druggable organelle -- P-glycoprotein-like transporters in Leishmania: a search for reversal agents -- Part V Strategies to circumvent drug resistance in Leishmania -- The relevance of susceptibility tests, breakpoints and markers -- The concept of fitness in Leishmania.
520 $a Drug resistance is a fundamental factor in treatment failure in diseases like leishmaniasis, although additional factors also play a role in this phenomenon. This volume is the second edition of a well-received book that provides a comprehensive update on the pathology of the disease, as well as on the concept of parasitic drug resistance, its molecular basis, consequences and possible treatments. A valuable resource for scientists both from academia and industry involved in biomedical research and drug design, the book provides the knowledge needed to understand leishmaniasis and to contibute to combatting this disease worldwide.
650 0 $a Drug resistance. $3 872072
650 0 $a Infectious diseases. $3 1102043
650 0 $a Pharmaceutical technology. $3 557391
650 0 $a Vaccines. $3 582184
650 0 $a Parasitology. $3 669054
650 0 $a Microbiology. $3 591510
650 1 4 $a Drug Resistance. $3 782695
650 2 4 $a Infectious Diseases. $3 668393
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
650 2 4 $a Vaccine. $3 782685
700 1 $a Ponte-Sucre, Alicia. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1072063
700 1 $a Padrón-Nieves, Maritza. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1282826
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319741857
776 0 8 $i Printed edition: $z 9783319741871
776 0 8 $i Printed edition: $z 9783030089306
856 4 0 $u https://doi.org/10.1007/978-3-319-74186-4
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)